presented by featuring special guest larry king schd19 · larry king as moderator minimizing cancer...
TRANSCRIPT
SCHD192019 Summit on National and Global
Cancer Health Disparities
April 27-28, 2019, Crowne Plaza Seattlehttp://cancersummit.binayfoundation.org
360-639-4063, [email protected]
Featuring special guest Larry King
Presented by
The 2019 Summit on National & Global Cancer Health Disparities (SCHD19) is the premier conference in the U.S. addressing disparities in cancer care. The conference features lectures, discussions and presidential-style debates among leaders across the spectrum of healthcare delivery. The goal of SCHD19 is to lead us in a direction to help hundreds of thousands of cancer patients who are still deprived of cutting-edge treatment.
WHAT IS SCHD19?
AudienceSCHD19 encourages cross-talk among different industries and sectors.
• Physicians, nurses, pharmacists
• Healthcare & industry executives
• Nonprofit leaders• Government
representatives• Patient advocates
*Audience from SCHD18
Lawmakers CEOs
AdvocatesExecutives
Physicians
PRESIDENTIAL-STYLE DEBATES
2019 Conference Partners
Advocates
PRESIDENTIAL-STYLE DEBATES
Timely topics, real debates
• Single-payer vs. multi-payer healthcare
• Is it time for FDA drug approval reform?
Featuring Larry King as moderator
Minimizing cancer health disparities requires a collaborative effort among all cancer health stakeholders. Unfortunately, cross-talk is uncommon among these groups. SCHD19’s unique debates are designed to break down these barriers and encourage collaboration to minimize disparities in cancer care.
FACULTY FACULTY
David Aboulafia, MDHematology & Oncology Section Head, Virginia Mason Medical Center
Benjamin Olney Anderson, MD, FACSChair and Director, Breast Health Global Initiative
Kenneth Anderson, MDKraft Family Professor of Medicine, Harvard Medical School
Otis Brawley, MDFormer CMO, American Cancer Society
Timothy Erickson, MDPhysician, Brigham & Women’s Hospital
Julie Gralow, MDBreast Medical Oncology, Seattle Cancer Care Alliance
Axel Grothey, MDConsultant, Wester Cancer Center
Bishal Gyawali, MDDepartment of Medicine, Brigham and Women’s Hospital
Bridgette HempsteadCEO & Founder, Cerra Sisters
Clifford A. Hudis, MD, FACP, FASCOCEO, American Society of Clinical Oncology
Jose Jeronimo, MDChief Technical Officer, Global Coalition against Cervical Cancer
Prabhat Jha, OC, MD, DPhil, FCAHSFounding Director, Center for Global Health Research
Saurabh Jha, MDAcademic Radiologist, University of Pennsylvania
Dr. Gary S. Kaplan, MD, FACP, FACMPE, FACPECEO, Virginia Mason Health System
Larry KingTelevision & Radio Host
Shaji Kumar, MDProfessor of Medicine, Mayo Clinic College of Medicine
Mark A. Lewis, MDDirector of Gastrointestinal Medical Oncology, Intermountain Healthcare
FACULTY
Gary H. Lyman, MD, MPHCo-Director, Hutchinson Institute for Cancer Outcomes
Mel Mann, MBA, M.Ed.Patient Advocate, Leukemia and Lymphoma Society
Renato Martins, MD, MPHProfessor of Medicine, University of Washington
Aju Mathew, MD, MPhil, FACPAssistant Professor of Medicine, University of Kentucky Markey Cancer Center
Chadi Nabhan, MD, MBA, FACPVice President & CMO, Cardinal Health Specialty Solutions
Saroj Niraula, MDOncologist, University of Manitoba & CancerCare Manitoba
John Pagel, MD, PhDChief of Hematologic Malignancies & Director of Stem Cell Transplant, Swedish Cancer Institute
Shilpen Patel, MDAssociate Professor, University of Washington Department of Global Health
Damiano Rondelli, MDChief of Division of Hematology & Oncology, University of Illinois Hospital & Health Sciences System
Rengaswamy Sankaranarayanan, MDSenior Visiting Scientist, WHO-IARC in Lyon, France
Elaine Schattner, MDClinical Associate Professor of Medicine, Weill Medical College
John R. Scheel, MD, PhD, MPHAttending Radiologist, Seattle Cancer Care Alliance
Binay Shah, MDFounder & President, Binaytara Foundation; Oncologist & Hematologist, PeaceHealth
Kelly Shanahan, MDMetastatic Breast Cancer Advocate
Adam SmithCongressman, Wash. District 9
Jeffery C. Ward, MDOncologist & Hematologist, Swedish Cancer Institute
Robert Winn, MDDirector, University of Illinois Cancer Center
DAY 1 - Saturday, April 27, 20197:00 – 7:45 am Registration/Breakfast
7:45 – 8:00 am Inauguration
8:00 – 9:30 am Addressing cancer health disparities: Race and beyond a. Racial and geographic disparities in the United States b. Innovative models to improve access to screening and cancer care c. ASCO’s efforts in reducing cancer health disparities
9:30 – 10:30 amClinical trials and cancer health disparities: RWE versus RCT a. RWE versus RCT b. Access to clinical trial in LMIC
10:30 – 11:00 amBreak/Exhibit
11:00 – 11:45 am Roundtable discussion: Drawing the line on buying time 11:45 am – 12:45 pmLunch/Poster presentation
12:45 – 1:45 pmGlobal cancer health disparities a. Geographic disparities in LMIC b. BTF’s pyramid model in improving access to cancer care
1:45 – 2:45 pmPreventable cancer burden: Current state and next steps
a. Hazards of smoking & benefits of cessation & taxation of tobaccob. HPV associated cancer
2:45 – 3:15 pm Break/Exhibit
3:15 – 4:45 pmDebate — Improving access to care: Single-payer versus multi-payer healthcare, moderated by Larry King
6:30 – 9:00 pmGala dinner
PROGRAM AGENDA PROGRAM AGENDARegister: http://cancersummit.binayfoundation.org
DAY 2 - Sunday, April 28, 20196:30 – 7:30 amRegistration/Breakfast
7:45 – 9:15 amCurrent efforts in reducing cancer health disparities
a. Cancer in patients with HIVb. Cancer in young adultsc. Cancer in LGBT
9:15 – 10:15 amAdvances in anticancer therapy delivery and cancer health disparities
a. Mechanism to address cancer health among victims of conflict and disasterb. Biosimilars in oncology, current state and future
10:15 – 10:45 amBreak
10:45 am – 12:15 pmDebate — Reform in FDA drug approval process: Is it desirable?Moderated by Larry King
PROGRAM AGENDA
CREDIT STATEMENT
This activity has been planned and implemented in accordance with the accreditation requirements and poli-cies of the Utah Medical Association (UMA) through the joint providership of the Ada Canyon Medical Educa-tion Consortium and the Binaytara Foundation. The Ada Canyon Medi-cal Education Consortium is accred-ited by the Utah Medical Association to provide continuing medical educa-
tion for physicians. The Ada Canyon Medical Education Consortium des-ignates this live activity for a maxi-mum of 7.75 AMA PRA Category 1 credit™ (s). Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Credits: Provider approved by the California Board of Registered Nursing, Provider # CEP17035, for 7.75 Contact Hours.
PROGRAM DIRECTORDr. Binay Shah
PROGRAM CHAIRSDr. Julie GralowDr. Gary Lyman
Register: http://cancersummit.binayfoundation.org
Cancellation policy: Email [email protected] to cancel your registration. Registrations cancelled on or before March 14, 2019, will receive 50% refund. No refunds issued after deadline.
